US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 7.590
  • +0.040+0.53%
Close Jul 23 16:00 ET
234.36MMarket Cap-2626P/E (TTM)

Acrivon Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.75%17.67M
105.48%67.1M
111.69%21.05M
68.53%16.14M
161.94%15.52M
99.57%14.39M
101.79%32.66M
132.90%9.95M
258.48%9.58M
5.93M
Selling and administrative expenses
33.66%6.2M
142.06%21.08M
36.54%5.58M
259.46%5.87M
170.51%5M
305.16%4.64M
253.12%8.71M
235.50%4.08M
258.90%1.63M
--1.85M
-General and administrative expense
33.66%6.2M
142.06%21.08M
36.54%5.58M
259.46%5.87M
170.51%5M
305.16%4.64M
253.12%8.71M
235.50%4.08M
258.90%1.63M
--1.85M
Research and development costs
17.58%11.47M
92.18%46.02M
164.04%15.48M
29.27%10.27M
158.06%10.52M
60.81%9.76M
74.58%23.95M
92.01%5.86M
258.39%7.94M
--4.08M
Operating profit
-22.75%-17.67M
-105.48%-67.1M
-111.69%-21.05M
-68.53%-16.14M
-161.94%-15.52M
-99.57%-14.39M
-101.79%-32.66M
-132.90%-9.95M
-258.48%-9.58M
-5.93M
Net non-operating interest income expense
-19.98%1.45M
1.81M
Non-operating interest income
-19.98%1.45M
----
----
----
----
--1.81M
----
----
----
----
Other net income (expense)
-55.29%-264K
350.67%6.72M
77.26%1.8M
343.24%1.67M
1,429.52%1.61M
-2,025.00%-170K
2,625.42%1.49M
1,491.78%1.02M
63.20%377K
105K
Other non- operating income (expenses)
-55.29%-264K
350.67%6.72M
77.26%1.8M
343.24%1.67M
1,429.52%1.61M
-2,025.00%-170K
2,625.42%1.49M
1,491.78%1.02M
63.20%377K
--105K
Income before tax
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
Income tax
Net income
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
Net income continuous Operations
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
---5.82M
Minority interest income
Net income attributable to the parent company
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
-5.82M
Basic earnings per share
-25.86%-0.73
63.76%-2.74
-8.75%-0.87
-34.97%-0.66
-39.75%-0.63
-3.71%-0.58
-500.86%-7.56
-137.81%-0.8
-158.73%-0.489
-0.4508
Diluted earnings per share
-25.86%-0.73
63.76%-2.74
-8.75%-0.87
-34.97%-0.66
-39.75%-0.63
-3.71%-0.58
-500.86%-7.56
-137.81%-0.8
-158.73%-0.489
-0.4508
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.75%17.67M105.48%67.1M111.69%21.05M68.53%16.14M161.94%15.52M99.57%14.39M101.79%32.66M132.90%9.95M258.48%9.58M5.93M
Selling and administrative expenses 33.66%6.2M142.06%21.08M36.54%5.58M259.46%5.87M170.51%5M305.16%4.64M253.12%8.71M235.50%4.08M258.90%1.63M--1.85M
-General and administrative expense 33.66%6.2M142.06%21.08M36.54%5.58M259.46%5.87M170.51%5M305.16%4.64M253.12%8.71M235.50%4.08M258.90%1.63M--1.85M
Research and development costs 17.58%11.47M92.18%46.02M164.04%15.48M29.27%10.27M158.06%10.52M60.81%9.76M74.58%23.95M92.01%5.86M258.39%7.94M--4.08M
Operating profit -22.75%-17.67M-105.48%-67.1M-111.69%-21.05M-68.53%-16.14M-161.94%-15.52M-99.57%-14.39M-101.79%-32.66M-132.90%-9.95M-258.48%-9.58M-5.93M
Net non-operating interest income expense -19.98%1.45M1.81M
Non-operating interest income -19.98%1.45M------------------1.81M----------------
Other net income (expense) -55.29%-264K350.67%6.72M77.26%1.8M343.24%1.67M1,429.52%1.61M-2,025.00%-170K2,625.42%1.49M1,491.78%1.02M63.20%377K105K
Other non- operating income (expenses) -55.29%-264K350.67%6.72M77.26%1.8M343.24%1.67M1,429.52%1.61M-2,025.00%-170K2,625.42%1.49M1,491.78%1.02M63.20%377K--105K
Income before tax -29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M
Income tax
Net income -29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M
Net income continuous Operations -29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M---5.82M
Minority interest income
Net income attributable to the parent company -29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M-5.82M
Basic earnings per share -25.86%-0.7363.76%-2.74-8.75%-0.87-34.97%-0.66-39.75%-0.63-3.71%-0.58-500.86%-7.56-137.81%-0.8-158.73%-0.489-0.4508
Diluted earnings per share -25.86%-0.7363.76%-2.74-8.75%-0.87-34.97%-0.66-39.75%-0.63-3.71%-0.58-500.86%-7.56-137.81%-0.8-158.73%-0.489-0.4508
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg